img

Global Infectious Disease Diagnostic Testing Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Infectious Disease Diagnostic Testing Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Infectious Disease Diagnostic Testing market is estimated at million US$ in 2021 and is expected to million US$ by the end of 2028, growing at a CAGR of % in the forecast period from 2022 to 2028.

This report studies the Infectious Disease Diagnostic Testing market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Infectious Disease Diagnostic Testing in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test

Market Snapshot, By Application
Hospitals
Scientific Research

Main Market Players Analyzed in this report, including
Zhejiang Orient Gene Biotech
Safecare Bio-Tech
Roche
Ortho Clinical Diagnostics
Mount Sinai Laboratory
Mayo Clinic Laboratories
Innovita Biological Technology
Henry Schein
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
Chembio Diagnostics
Cellex
BioMedomics
BD
ADVAITE
Abbott

The study objectives of this report are
To study and analyze the global Infectious Disease Diagnostic Testing market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Infectious Disease Diagnostic Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Infectious Disease Diagnostic Testing manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Infectious Disease Diagnostic Testing market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Infectious Disease Diagnostic Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Infectious Disease Diagnostic Testing are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Infectious Disease Diagnostic Testing Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Infectious Disease Diagnostic Testing Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Infectious Disease Diagnostic Testing

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Hospitals
3.2.2 Major Buyers in Scientific Research

4 Market Segment: by Type
4.1 Infectious Disease Diagnostic Testing Type Introduction
4.1.1 Molecular Diagnostic Test
4.1.2 POC Infectious Disease Diagnostics Test
4.2 Global Infectious Disease Diagnostic Testing Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Infectious Disease Diagnostic Testing Type Introduction
5.1.1 Hospitals
5.1.2 Scientific Research
5.2 Global Infectious Disease Diagnostic Testing Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Infectious Disease Diagnostic Testing Market by Region
6.2 North America Infectious Disease Diagnostic Testing Market 2016-2021
6.3 Europe Infectious Disease Diagnostic Testing Market 2016-2021
6.4 Asia Pacific Infectious Disease Diagnostic Testing Market 2016-2021
6.5 South America Infectious Disease Diagnostic Testing Market 2016-2021
6.6 Middle East and Africa Infectious Disease Diagnostic Testing Market 2016-2021

7 North America
7.1 North America Infectious Disease Diagnostic Testing Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Infectious Disease Diagnostic Testing Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Infectious Disease Diagnostic Testing Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Infectious Disease Diagnostic Testing Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Infectious Disease Diagnostic Testing Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zhejiang Orient Gene Biotech
12.1.1 Zhejiang Orient Gene Biotech Company Information
12.1.2 Zhejiang Orient Gene Biotech Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.1.3 Zhejiang Orient Gene Biotech Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.1.4 Zhejiang Orient Gene Biotech Key Development
12.2 Safecare Bio-Tech
12.2.1 Safecare Bio-Tech Company Information
12.2.2 Safecare Bio-Tech Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.2.3 Safecare Bio-Tech Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.2.4 Safecare Bio-Tech Key Development
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.3.3 Roche Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.3.4 Roche Key Development
12.4 Ortho Clinical Diagnostics
12.4.1 Ortho Clinical Diagnostics Company Information
12.4.2 Ortho Clinical Diagnostics Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.4.3 Ortho Clinical Diagnostics Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.4.4 Ortho Clinical Diagnostics Key Development
12.5 Mount Sinai Laboratory
12.5.1 Mount Sinai Laboratory Company Information
12.5.2 Mount Sinai Laboratory Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.5.3 Mount Sinai Laboratory Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.5.4 Mount Sinai Laboratory Key Development
12.6 Mayo Clinic Laboratories
12.6.1 Mayo Clinic Laboratories Company Information
12.6.2 Mayo Clinic Laboratories Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.6.3 Mayo Clinic Laboratories Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.6.4 Mayo Clinic Laboratories Key Development
12.7 Innovita Biological Technology
12.7.1 Innovita Biological Technology Company Information
12.7.2 Innovita Biological Technology Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.7.3 Innovita Biological Technology Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.7.4 Mayo Clinic Laboratories Key Development
12.9 Guangzhou Wondfo Biotech
12.9.1 Guangzhou Wondfo Biotech Company Information
12.9.2 Guangzhou Wondfo Biotech Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.9.3 Guangzhou Wondfo Biotech Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.9.4 Guangzhou Wondfo Biotech Key Development
12.8 Henry Schein
12.8.1 Henry Schein Company Information
12.8.2 Henry Schein Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.8.3 Henry Schein Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.8.4 Henry Schein Key Development
12.11 Dynamiker Biotechnology (Tianjin)
12.11.1 Dynamiker Biotechnology (Tianjin) Company Information
12.11.2 Dynamiker Biotechnology (Tianjin) Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.11.3 Dynamiker Biotechnology (Tianjin) Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.11.4 Dynamiker Biotechnology (Tianjin) Key Development
12.12 Chembio Diagnostics
12.12.1 Chembio Diagnostics Company Information
12.12.2 Chembio Diagnostics Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.12.3 Chembio Diagnostics Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.12.4 Chembio Diagnostics Key Development
12.13 Cellex
12.13.1 Cellex Company Information
12.13.2 Cellex Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.13.3 Cellex Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.13.4 Cellex Key Development
12.14 BioMedomics
12.14.1 BioMedomics Company Information
12.14.2 BioMedomics Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.14.3 BioMedomics Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.14.4 BioMedomics Key Development
12.15 BD
12.15.1 BD Company Information
12.15.2 BD Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
12.15.3 BD Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
12.15.4 BD Key Development
12.17 Abbott

13 Global Infectious Disease Diagnostic Testing Market Forecast by Region by Type and by Application
13.1 Global Infectious Disease Diagnostic Testing Revenue Forecast 2022-2027
13.2 Global Infectious Disease Diagnostic Testing Forecast by Regions
13.3 Global Infectious Disease Diagnostic Testing Forecast by Type
13.4 Global Infectious Disease Diagnostic Testing Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Infectious Disease Diagnostic Testing Production Specifications
Table 2: Drivers in Infectious Disease Diagnostic Testing Market
Table 3: Restraints Infectious Disease Diagnostic Testing Market
Table 4: Opportunity in Infectious Disease Diagnostic Testing Market
Table 5: Comparion of Alternative and Infectious Disease Diagnostic Testing
Table 6: Infectious Disease Diagnostic Testing Raw Materials Key Suppliers List
Table 7: Infectious Disease Diagnostic Testing Distributors List
Table 8: Infectious Disease Diagnostic Testing Major Buyers in Application One
Table 9: Infectious Disease Diagnostic Testing Major Buyers in Application Two
Table 10: Infectious Disease Diagnostic Testing Major Buyers in Application Three
Table 11: Global Infectious Disease Diagnostic Testing Revenue (Million USD) by Type 2016-2021
Table 12: Global Infectious Disease Diagnostic Testing Revenue Market Share by Type 2016-2021
Table 18: Global Infectious Disease Diagnostic Testing Revenue (Million USD) by Application 2016-2021
Table 19: Global Infectious Disease Diagnostic Testing Revenue Market Share by Application 2016-2021
Table 20: Global Infectious Disease Diagnostic Testing Revenue (Million USD) by Region 2016-2021
Table 21: Global Infectious Disease Diagnostic Testing Revenue Market Share by Region 2016-2021
Table 22: North America Infectious Disease Diagnostic Testing Revenue (Million USD) by Country 2016-2021
Table 23: North America Infectious Disease Diagnostic Testing Revenue Market Share by Country 2016-2021)
Table 24: Europe Infectious Disease Diagnostic Testing Revenue (Million USD) by Country 2016-2021
Table 25: Europe Infectious Disease Diagnostic Testing Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Infectious Disease Diagnostic Testing Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Infectious Disease Diagnostic Testing Revenue Market Share by Country 2016-2021)
Table 28: South America Infectious Disease Diagnostic Testing Revenue (Million USD) by Country 2016-2021
Table 29: South America Infectious Disease Diagnostic Testing Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Infectious Disease Diagnostic Testing Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Infectious Disease Diagnostic Testing Revenue Market Share by Country 2016-2021)
Table 32 Zhejiang Orient Gene Biotech Company Information
Table 33 Zhejiang Orient Gene Biotech Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 34 Zhejiang Orient Gene Biotech Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 35 Safecare Bio-Tech Company Information
Table 36 Safecare Bio-Tech Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 37 Safecare Bio-Tech Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 38 Roche Company Information
Table 39 Roche Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 40 Roche Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 41 Ortho Clinical Diagnostics Company Information
Table 42 Ortho Clinical Diagnostics Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 43 Ortho Clinical Diagnostics Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 44 Mount Sinai Laboratory Company Information
Table 45 Mount Sinai Laboratory Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 46 Mount Sinai Laboratory Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 47 Mayo Clinic Laboratories Company Information
Table 48 Mayo Clinic Laboratories Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 49 Mayo Clinic Laboratories Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 50 Innovita Biological Technology Company Information
Table 51 Innovita Biological Technology Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 52 Innovita Biological Technology Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 53 Henry Schein Company Information
Table 54 Henry Schein Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 55 Henry Schein Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 56 Guangzhou Wondfo Biotech Company Information
Table 57 Guangzhou Wondfo Biotech Infectious Disease Diagnostic Testing Product Portfolio, Specification and Application
Table 58 Guangzhou Wondfo Biotech Infectious Disease Diagnostic Testing Revenue and Gross Margin (2019-2021)
Table 59: Global Infectious Disease Diagnostic Testing Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Infectious Disease Diagnostic Testing Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Infectious Disease Diagnostic Testing Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Infectious Disease Diagnostic Testing Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Infectious Disease Diagnostic Testing Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Infectious Disease Diagnostic Testing Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Infectious Disease Diagnostic Testing Picture
Figure 2: Global Infectious Disease Diagnostic Testing Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Infectious Disease Diagnostic Testing Industry Life Cycle
Figure 5: Product Picture of Molecular Diagnostic Test
Figure 6: Product Picture of POC Infectious Disease Diagnostics Test
Figure 9: Global Infectious Disease Diagnostic Testing Revenue Market Share by Type, 2020
Figure 10: Infectious Disease Diagnostic Testing in Hospitals
Figure 11: Global Infectious Disease Diagnostic Testing Market: Hospitals 2016-2021
Figure 12: Infectious Disease Diagnostic Testing in Scientific Research
Figure 13: Global Infectious Disease Diagnostic Testing Market: Scientific Research 2016-2021
Figure 14: Global Infectious Disease Diagnostic Testing Revenue Market Share by Application, 2020
Figure 15: Global Infectious Disease Diagnostic Testing Revenue Market Share by Region 2016-2021
Figure 16: North America Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 7: Europe Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 8: Asia Pacific Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 9: South America Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 10: Middle East and Africa Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 11: North America Infectious Disease Diagnostic Testing Revenue Market Share by Country, 2020
Figure 12: United States Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 13: Canada Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 14: Mexico Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 15: Europe Infectious Disease Diagnostic Testing Revenue Market Share by Country, 2020
Figure 16: Germany Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 17: France Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 18: UK Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 19: Italy Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 20: Russia Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 21: Spain Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Infectious Disease Diagnostic Testing Revenue Market Share by Country, 2020
Figure 23: China Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 24: Japan Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 25: Korea Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 26: Southeast Asia Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 27: India Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 28: Australia Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 29: South America Infectious Disease Diagnostic Testing Revenue Market Share by Country, 2020
Figure 30: Brazil Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 31: Argentina Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 32: Colombia Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 33: Middle East and Africa Infectious Disease Diagnostic Testing Revenue Market Share by Country, 2020
Figure 34: Turkey Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 35: Saudi Arabia Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 36: South Africa Infectious Disease Diagnostic Testing Revenue (Million USD) Status 2016-2021
Figure 37: Zhejiang Orient Gene Biotech Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 38: Safecare Bio-Tech Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 39: Roche Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 40: Ortho Clinical Diagnostics Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 41: Mount Sinai Laboratory Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 42: Mayo Clinic Laboratories Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 43: Innovita Biological Technology Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 44: Henry Schein Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 45: Guangzhou Wondfo Biotech Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 46: Guangdong Hecin-Scientific Infectious Disease Diagnostic Testing Revenue Market Share Globally (2019-2021)
Figure 47: Global Infectious Disease Diagnostic Testing Revenue (Million USD) Forecast (2022-2027)